title: [Oncologic indications and contra-indications for hormones use in menopause].
abstract: The life expectation has been changeable the manner of menopause handling. At the same time, the women after fifty have the highest incidence of cancer. The hormonal replacement therapy (HT) to date have very few indication for patients with cancer. The oncologic contraindication for HT are analysed in detail, particulary for breast tumor. At the present time, the studies and the metanalysis on HT and breat cancer not showed a quantitative increase on the risk. We are looking for selective hormone with antagonist for endometrium and breast receptors, and effectiveness on the others areas.
authors.affiliation: Universidad Nacional de Córdoba.
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Sarriá
mesh_terms: D001943:Breast Neoplasms / Q000139:chemically induced; D015179:Colorectal Neoplasms / Q000139:chemically induced; D000075202:Contraindications; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D019584:Hot Flashes / Q000188:drug therapy*; D006801:Humans; D008593:Menopause; D009369:Neoplasms / Q000139:chemically induced*; D010051:Ovarian Neoplasms / Q000737:chemistry; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use
chemical_list: D020845:Selective Estrogen Receptor Modulators